TORONTO–(BUSINESS WIRE)– #ARDS–Vasomune receives up to C$280,347 from NRC IRAP to develop a subcutaneous form of its investigational vascular leak therapy, Pegevongitide.
Tag: Vasomune
Recent
Medtronic announces new prospective, global clinical evidence from the Spectrum Program for VenaSeal™ closure system in advanced chronic venous disease
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
AHN Cardiology Department at Allegheny General Hospital Launches Clinical Trial Investigating New Therapy for Pulmonary Arterial Hypertension
Popular
- No commented posts yet